-
241
-
242
-
243
-
244por Obata, Shota, Hidaka, Sumi, Yamano, Mizuki, Yanai, Mitsuru, Ishioka, Kunihiro, Kobayashi, Shuzo“…We herein report a case of MPO-anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis following the mRNA vaccine BNT162b2 (Pfizer/BioNTech) for COVID-19. Although the causal relationship between vaccine and ANCA-associated vasculitis is uncertain, environmental and genetic factors may have set the stage for the development of vasculitis, and the vaccine may have triggered a domino effect.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
245
-
246“…BACKGROUND: In this case report, we describe a potential association between the Pfizer-BioNTech COVID-19 vaccine and development of a vulvar aphthous ulcer in a virginal 14-year-old girl. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
247“…INTRODUCTION: Le vaccin Pfizer est un vaccin à ARN messager. De rares cas de réaction d’hypersensibilité immédiate ont été rapportés. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
248por Hargreaves Heap, Shaun P., Koop, Christel, Matakos, Konstantinos, Unan, Aslı, Weber, Nina“…The announcement of Pfizer/BioNTech’s COVID-19 vaccine success on November 9, 2020 led to a global stock market surge. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
249
-
250“…This presentation could also simply be a very unique, isolated case, and that each individual should have no hesitations regarding the Pfizer-BioNTech COVID-19 vaccine. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
251por Chachar, Tarique S, Yousif, Nooraldaem, Sulaibikh, Leena, Abdulqader, Fuad, Alqahtani, Manaf“…We present a case of a 24-year-old male patient who presented to our institution five days after receiving his first dose of Pfizer-BioNTech vaccine to rule out acute coronary syndrome due to chest pain along with troponin increase and ECG changes. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
252por Palaia, Innocenza, Caruso, Giuseppe, Di Donato, Violante, Vestri, Annarita, Napoli, Anna, Perniola, Giorgia, Casinelli, Matteo, Alunni Fegatelli, Danilo, Campagna, Roberta, Tomao, Federica, D’Aniello, Debora, Antonelli, Guido, Muzii, Ludovico“…Objective: To evaluate the safety and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in gynecologic oncology patients under chemotherapy. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
253
-
254
-
255
-
256
-
257
-
258por Giuffrida, Gaetano, Condorelli, Annalisa, Di Giorgio, Mary Ann, Markovic, Uros, Sciortino, Roberta, Nicolosi, Daniela, Di Raimondo, FrancescoEnlace del recurso
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
259por Cham, Jason, Pandey, Amitabh C., New, Jacob, Huynh, Tridu, Hong, Lee, Orendain, Natalia, Topol, Eric J., Nicholson, Laura J.“…AIM: Healthcare workers (HCWs) were among the first group of people vaccinated with the Pfizer-BioNTech Covid-19 vaccine (BNT162b2). Characterization of the kinetics of antibody response to vaccination is important to devise future vaccination strategies. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
260